CRL
Charles River Laboratories International Inc.

912
Mkt Cap
$10.39B
Volume
402,997.00
52W High
$228.88
52W Low
$91.86
PE Ratio
-137.12
CRL Fundamentals
Price
$213.22
Prev Close
$210.48
Open
$208.86
50D MA
$200.28
Beta
1.41
Avg. Volume
690,876.25
EPS (Annual)
$0.1994
P/B
3.08
Rev/Employee
$201,491.99
Loading...
Loading...
News
all
press releases
Revvity (RVTY) Q4 Earnings and Revenues Beat Estimates
Revvity (RVTY) delivered earnings and revenue surprises of +4.29% and +0.02%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·20h ago
News Placeholder
More News
News Placeholder
Y Intercept Hong Kong Ltd Invests $1.18 Million in Charles River Laboratories International, Inc. $CRL
Y Intercept Hong Kong Ltd purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the third quarter, according to the company in its most recent filing...
MarketBeat·2d ago
News Placeholder
HCA Healthcare (HCA) Beats Q4 Earnings Estimates
HCA (HCA) delivered earnings and revenue surprises of +8.90% and -0.63%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7d ago
News Placeholder
Universal Beteiligungs und Servicegesellschaft mbH Grows Stock Position in Charles River Laboratories International, Inc. $CRL
Universal Beteiligungs und Servicegesellschaft mbH increased its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 154.0% in the 3rd quarter, according to...
MarketBeat·8d ago
News Placeholder
Charles River Laboratories International, Inc. $CRL Shares Acquired by Cooke & Bieler LP
Cooke & Bieler LP increased its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 0.9% during the 3rd quarter, according to the company in its most recent Form 13F...
MarketBeat·8d ago
News Placeholder
Charles River Laboratories International, Inc. (NYSE:CRL) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the fifteen brokerages that are covering the company...
MarketBeat·11d ago
News Placeholder
77,056 Shares in Charles River Laboratories International, Inc. $CRL Bought by Rakuten Investment Management Inc.
Rakuten Investment Management Inc. bought a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the 3rd quarter, according to its most recent disclosure...
MarketBeat·12d ago
News Placeholder
Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2025 financial results and provide 2026 guidance on Wednesday, February 18th, before the market...
Business Wire·12d ago
News Placeholder
Charles River Enters Manufacturing Collaboration with Gazi University
Charles River Laboratories International, Inc. (NYSE: CRL) and Gazi University Faculty of Medicine, today announced a gene therapy contract development and manufacturing organization (CDMO...
Business Wire·13d ago
News Placeholder
Charles River Laboratories International (NYSE:CRL) EVP Sells $65,488.00 in Stock
Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) EVP Joseph Laplume sold 400 shares of the firm's stock in a transaction dated Friday, August 22nd. The shares were sold at...
MarketBeat·13d ago
<
1
2
...
>

Latest CRL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.